In most of published studies conventional RT achieves tumor growth control in 85-95% of cases, dropping out GH/IGF-I levels to less than 5 ng/ml in up to 80% of patients 10-15 years after RT [6]. This evidence concerns the gene IGF1 and neoplasm.